Christina Henson

Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial

Loren K. Mell, Pedro A. Torres‐Saavedra, Stuart J. Wong et al. · The Lancet Oncology · 2024 · 44 citations · Full text

Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC).

Steven J. Frank, Paul M. Busse, David I. Rosenthal et al. · Journal of Clinical Oncology · 2024 · 41 citations

Cancer Management, Treatment Verification, Physical Properties +20

Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations

Christina Henson, Ahmad K Abou-Foul, Eugene Yu et al. · The Lancet Oncology · 2024 · 41 citations

Neck Cancer, Radiological Imaging, Oncologic Imaging +12

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer

Sushmita Gordhandas, Beryl Manning‐Geist, Christina Henson et al. · Scientific Reports · 2022 · 30 citations · Full text

Intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for the treatment of head and neck cancer: A dosimetric comparison

My‐Lien Nguyen, J. Nathan Cantrell, Salahuddin Ahmad et al. · Medical dosimetry · 2021 · 24 citations

Intensity-modulated Proton Therapy, Neck Cancer, Radiation Therapy +8